636 results on '"Miners, John O."'
Search Results
202. Determinants of acetaminophen metabolism: Effect of inducers and inhibitors of drug metabolism on acetaminophen's metabolic pathways.
203. The Analysis of Penicillins in Biological Fluids and Pharmaceutical Preparations by High-Performance Liquid Chromatography: A Review.
204. Cytochrome P4502C9: an enzyme of major importance in human drug metabolism.
205. Limited value of the urinary phenytoin metabolic ratio for the assessment of cytochrome P4502C9 activity in vivo.
206. Microbiological hydroxylation. Part XXI. Hydroxylations of 3-halogeno-17-oxo-, 3-halogeno-7-oxo-, and 17-halogeno-3-oxo-androstanes by the fungi Calonectria decora, Rhizopus nigricans, and Aspergillus ochraceus.
207. Microbiological hydroxylation. Part XX. Hydroxylation of dioxygenated 5α-androstanes with the fungi Absidia regnieri and Syncephelastrum racemosum.
208. Microbiological hydroxylation. Part XVI. Incubation of derivatives (mainly acetals) of 5α-androstane ketones with the fungi Calonectria decora, Aspergillus ochraceus, and Rhizopus nigricans.
209. Microbiological hydroxylation. Part XVII. C-19 hydroxylation of 17-oxo-5α-androstanes and 17-oxo-3α,5-cyclo-5α-androstanes by the fungus Calonectria decora.
210. Microbiological hydroxylation. Part XV. Hydroxylation in the terminal rings of mono- and di-oxygenated 5α-androstanes with the fungus Daedalea rufescens.
211. Microbiological hydroxylation. Part XIV. Hydroxylation in the terminal rings of dioxygenated 5α-androstanes with the fungi Wojnowicia graminis and Ophiobolus herpotrichus.
212. The role of the CFP2C9-Leu 359 allelic variant in the tolbutamide polymorphism.
213. Nonlinear Metabolic Disposition of Theophylline.
214. Recent Advances in the In Silico Modelling of UDP Glucuronosyltransferase Substrates
215. Human Renal Cortical and Medullary UDP-Glucuronosyltransferases (UGTs): Immunohistochemical Localization of UGT2B7 and UGT1A Enzymes and Kinetic Characterization of S-Naproxen Glucuronidation.
216. How to treat Pharmacogenetics.
217. IN VITRO CHARACTERIZATION OF LAMOTRIGINE N2-GLUCURONIDATION AND THE LAMOTRIGINE-VALPROIC ACID INTERACTION
218. SELECTIVITY OF SUBSTRATE (TRIFLUOPERAZINE) AND INHIBITOR (AMITRIPTYLINE, ANDROSTERONE, CANRENOIC ACID, HECOGENIN, PHENYLBUTAZONE, QUINIDINE, QUININE, AND SULFINPYRAZONE) "PROBES" FOR HUMAN UDP-GLUCURONOSYLTRANSFERASES
219. Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping.
220. Preface
221. Macrolide–theophylline interactions: no role for the inhibition of cytochrome P4501A2.
222. Non-selective nonsteroidal anti-inflammatory drugs and cardiovascular events: is aldosterone the silent partner in crime?
223. The role of the CFP2C9-Leu 359allelic variant in the tolbutamide polymorphism
224. Biochemical validation of self-reported caffeine consumption during caffeine fading
225. Response to <italic>in vitro</italic> and physiologically‐based pharmacokinetic assessment of the drug–drug interaction potential of canagliflozin.
226. Inhibitory effects of non-steroidal anti-inflammatory drugs on human liver microsomal morphine glucuronidation: Implications for drug-drug interaction liability
227. Microbiological hydroxylation. Part XIX. The action of an ant fungus (‘Acromyrmex fungus’) on oxygenated androstanes, pregnanes, and cholestanes.
228. Microbiological hydroxylation. Part XVIII. Introduction of 16α-, 9α-, and 3α-hydroxy-groups into dioxygenated 5α-androstanes by the fungus Diaporthe celastrina.
229. ChemInform Abstract: MICROBIOLOGICAL HYDROXYLATION PART 18, INTRODUCTION OF 16ALPHA-, 9ALPHA-, AND 3ALPHA-HYDROXY-GROUPS INTO DIOXYGENATED 5ALPHA-ANDROSTANES BY THE FUNGUS DIAPORTHE CELASTRINA
230. Additivity relations in carbon-13 nuclear magnetic resonance spectra of dihydroxy steroids
231. Characterisation of theophylline metabolism by human liver microsomes
232. 16β,18-Dihydroxylation of oxygenated 5α-androstanes with the fungus Leptoporus fissilis
233. ChemInform Abstract: MICROBIOLOGICAL HYDROXYLATION PART 19, THE ACTION OF AN ANT FUNGUS (′ACROMYRMEX FUNGUS′) ON OXYGENATED ANDROSTANES, PREGNANES, AND CHOLESTANES
234. Tolbutamide hydroxylation by human liver microsomes
235. Drug Interactions Involving Aspirin (Acetylsalicylic Acid) and Salicylic Acid
236. ChemInform Abstract: MICROBIOLOGICAL HYDROXYLATION PART 16, INCUBATION OF DERIVATIVES (MAINYL ACETALS) OF 5ALPHA‐ANDROSTANE KETONES WITH THE FUNGI CALONECTRIA DECORA, ASPERGILLUS OCHRACENS AND RHIZOPUS NIARICANS
237. ChemInform Abstract: PREPARATION OF 3β-HYDROXY-5α-ANDROSTAN-16-ONE
238. Preparation of 3β-hydroxy-5α-androstan-16-one
239. ChemInform Abstract: MICROBIOLOGICAL HYDROXYLATION PART 7, C‐19‐HYDROXYLATION OF 17‐OXO‐5ALPHA‐ANDROSTANES AND 17‐OXO‐3ALPHA,5‐CYCLO‐5ALPHA‐ANDROSTANES BY THE FUNGUS CALONECTRIA DECORA
240. ChemInform Abstract: MICROBIOLOGICAL HYDROXYLATION. XXI. HYDROXYLATIONS OF 3‐HALO‐17‐OXO‐3‐HALO‐7‐OXO‐, AND 17‐HALO‐3‐OXOANDROSTANES BY THE FUNGI CALONECTRIA DECORA, RHIZOPUS NIGRICANS, AND ASPERGILLUS OCHRACEUS
241. ChemInform Abstract: MICROBIOLOGICAL HYDROXYLATION PART 14, HYDROXYLATION IN THE TERMINAL RINGS OF DIOXYGENATED 5ALPHA-ANDROSTANES WITH THE FUNGI WOJNOWICIA GRAMINIS AND OPHIOBOLUS HERPOTRICHUS
242. Mechanism of action of paracetamol protective agents in mice in vivo
243. Effect of cimetidine on paracetamol activation in mice
244. ChemInform Abstract: MICROBIOLOGICAL HYDROXYLATION PART 15, HYDROXYLATION IN THE TERMINAL RINGS OF MONO‐ AND DI‐OXYGENATED 5ALPHA‐ANDROSTANES WITH THE FUNGUS DAEDALEA RUFESCENS
245. ChemInform Abstract: MICROBIOLOGICAL HYDROXYLATION. XX. HYDROXYLATION OF DIOXYGENATED 5α-ANDROSTANES WITH THE FUNGI ABSIDIA REGNIERI AND SYNCEPHELASTRUM RACEMOSUM
246. Radiometric high-performance liquid chromatographic procedure for the determination of theobromine metabolites in microsomal incubations
247. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation
248. Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma.
249. The molecular basis of dapsone activation of CYP2C9-catalyzed nonsteroidal anti-inflammatory drug oxidation.
250. What's in a name?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.